GlassScriptPhysician profile
Cullan R Reilly
NPI 1043581812
$1,807.01
in general payments reported to CMS, 2019-2025
8 companies · $36.41 in 2025
The $36.41 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2021: $17.57 · 2022: $1,407 · 2023: $45.76 · 2024: $77.65 · 2025: $36.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $1,281.20 | 2021-2024 | |
| Treace Medical Concepts, INC. | $193.07 | 2022 | |
| Osiris Therapeutics INC. | $128.53 | 2019 | |
| Amniox Medical, INC. | $93.75 | 2019 | |
| Smith+Nephew, INC. | $49.66 | 2024-2025 | Grafix Pl |
| Averitas Pharma INC. | $24.75 | 2024 | Qutenza |
| Medtronic, INC. | $21.40 | 2023 | Intellis Adaptivestim |
| Cashflow Solutions, LLC | $14.65 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cullan Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.